Stanley C. Jordan, MD

Dr. Stanley Jordan is a world-renowned leader in the field of transplant medicine & immunology and serves as our Chief Scientific Officer. Dr. Jordan is also Director, Nephrology Transplant Immunology and Medical Director, Kidney Transplant Program at Cedars-Sinai Medical Center and Distinguished Professor of Pediatrics & Medicine at the David Geffen School of Medicine, UCLA. Dr. Jordan is recognized internationally for his three decades of research focusing on the immunology of antibody rejection and development of novel immune modulatory therapies to combat this condition. Dr. Jordan has extensive experience with desensitization for incompatible kidney transplantation and has an active clinical trials program examining novel therapies for desensitization and treatment of antibody-mediated rejection. He has also published novel clinical trials using complement inhibitors to prevent delayed graft function in renal allografts. Dr. Jordan and his work have been recognized by his peers and include his being the recipient of the National Kidney Foundation “Gift of Life Award” and the Distinguished Alumni Award from the University of North Carolina Chapel Hill. He was honored with the inaugural Cedars-Sinai Prize for Research in Scientific Medicine (PRISM),conceived to recognize outstanding scientific and medical breakthroughs, the Pioneer in Medicine Award (also from Cedars-Sinai), the Award for Outstanding Achievement in Transplantation from the Transplantation Society, the Jean Hamburger Award for outstanding research in nephrology from the International Society of Nephrology and the Senior Achievement Award in Clinical Transplantation from the American Society of Transplantation. In 2020 Dr. Jordan was awarded the Sir Peter Medawar Prize in Transplantation. This award is recognized as one of the world’s most important awards in scientific medicine, and is the highest award given in transplantation.